New Vaccine Deal Slashes Malaria Vaccine Cost, Expands Protection for Millions
Geneva - Gavi, the Vaccine Alliance, and UNICEF have announced a landmark agreement that will dramatically reduce the cost of the highly effective R21/Matrix-M™ malaria vaccine and unlock millions of additional doses, marking a major turning point in the global effort to combat one of the world's deadliest infectious diseases.
The new deal reduces the price of the R21/Matrix-M™ vaccine to US 2.99 per dose, a significant cut expected to take effect within the next year. This sharp reduction is projected to save up to US 90 million for Gavi and implementing countries, enabling the full vaccination of nearly 7 million more children and securing more than 30 million additional vaccine doses over the next five years.
Financing Innovation Accelerates Access
The breakthrough was made pos...









